Searched for
AI IN DRUG DISCOVERY
Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...- Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman saysHedge funds are actively enhancing their stakes in healthcare stocks, reflecting a significant trend in market behavior. With a notable sur...
- The fear before the grief: When goodbye begins long before it actually happensThe death of a parent is one of life's oldest certainties. Yet for many millennials and Gen Z adults, it is an all-consuming preoccupation....
- Temasek doubles down on India; sees long-term opportunities in family businessesTemasek International sees family businesses opening to investors as a major market shift. Generational transitions create attractive long-...
- US to spend $5 billion on health, construction research powered by AIThe United States will allocate five billion dollars for scientific research. This funding will address chronic diseases and accelerate dru...
- Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...
- Bristol Myers buys Nvidia's latest AI computing system for drug researchBristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...
- Match Your AI Strategy to Your Organization’s RealityArtificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...
- Rare earth minerals explained: Why are they the world's most strategic resources?Rare earth minerals explained: Rare earths are vital for modern technology and defense applications. China dominates global processing, cre...
- Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's LaboratoriesDr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He ...
- Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- The hidden reason global capital is looking beyond India for future growthForeign investors are reallocating capital away from India towards markets like Taiwan and South Korea that offer stronger exposure to AI a...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Karnataka explores biotech financing framework, AI-led innovation to support sector growthKarnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...
- Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...
- AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
Load More
